AGF Investments LLC’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-96
Closed -$5K 628
2019
Q3
$5K Hold
96
﹤0.01% 538
2019
Q2
$5K Sell
96
-5,417
-98% -$263K ﹤0.01% 580
2019
Q1
$256K Buy
5,513
+2,177
+65% +$110K 0.06% 178
2018
Q4
$164K Buy
3,336
+2,181
+189% +$124K 0.02% 304
2018
Q3
$72K Sell
1,155
-238
-17% -$14.5K 0.01% 306
2018
Q2
$76K Buy
1,393
+190
+16% +$9.49K 0.01% 310
2018
Q1
$60K Buy
+1,203
New +$51.6K 0.01% 284
2017
Q4
Sell
-1,560
Closed -$58K 767
2017
Q3
$58K Buy
1,560
+145
+10% +$5.17K 0.01% 216
2017
Q2
$54K Buy
1,415
+95
+7% +$3.48K 0.01% 242
2017
Q1
$45K Sell
1,320
-322
-20% -$10.6K 0.01% 199
2016
Q4
$55K Buy
+1,642
New +$53.3K 0.01% 224

Other funds holding EHC

AGF Investments LLC's EHC Position: Q4 2019 in Review

AGF Investments LLC sold out of Encompass Health (EHC) in Q4 2019, closing a stake of 96 shares — an estimated $5K sold.

AGF Investments LLC first reported a position in EHC in Q4 2016 and held it in 11 quarters. The position peaked at $256K in Q1 2019. 397 funds tracked by Wall St. Rank hold EHC as of Q4 2019.

  • AGF Investments LLC reported no remaining Encompass Health position as of Q4 2019 after selling out during the quarter.
  • AGF Investments LLC sold 96 Encompass Health shares in Q4 2019, an estimated $5K.
  • AGF Investments LLC first reported a position in Encompass Health in Q4 2016 and held it in 11 quarters.
  • AGF Investments LLC's Encompass Health position peaked at $256K in Q1 2019.
  • 397 funds tracked by Wall St. Rank held Encompass Health as of Q4 2019.

Based on AGF Investments LLC's 13F filing for Q4 2019, filed 12 Feb 2020.